These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19541428)

  • 1. Neuropsychological functioning in health and mood disorder: Modulation by glucocorticoids and their receptors.
    Gallagher P; Reid KS; Ferrier IN
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S196-207. PubMed ID: 19541428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.
    Marques AH; Silverman MN; Sternberg EM
    Ann N Y Acad Sci; 2009 Oct; 1179():1-18. PubMed ID: 19906229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future therapeutic targets in mood disorders: the glucocorticoid receptor.
    McQuade R; Young AH
    Br J Psychiatry; 2000 Nov; 177():390-5. PubMed ID: 11059990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin.
    McAllister-Williams RH; Ferrier IN; Young AH
    Psychol Med; 1998 May; 28(3):573-84. PubMed ID: 9626714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of anti-glucocorticoid therapy for stress-related diseases.
    Martocchia A; Stefanelli M; Falaschi GM; Toussan L; Rocchietti March M; Raja S; Romano G; Falaschi P
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):79-87. PubMed ID: 23489288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity in the hypothalamic-pituitary-adrenal axis and delirium.
    Olsson T
    Dement Geriatr Cogn Disord; 1999; 10(5):345-9. PubMed ID: 10473937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders.
    Watson S; Gallagher P; Ferrier IN; Young AH
    J Psychiatr Res; 2006 Jun; 40(4):353-9. PubMed ID: 16165159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol in mood disorders.
    Young AH
    Stress; 2004 Dec; 7(4):205-8. PubMed ID: 16019585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis and bipolar disorder.
    Daban C; Vieta E; Mackin P; Young AH
    Psychiatr Clin North Am; 2005 Jun; 28(2):469-80. PubMed ID: 15826743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.
    Pariante CM
    Ann N Y Acad Sci; 2009 Oct; 1179():144-52. PubMed ID: 19906237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and the genesis of depressive illness. A psychobiological model.
    Dinan TG
    Br J Psychiatry; 1994 Mar; 164(3):365-71. PubMed ID: 7832833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions.
    Wingenfeld K; Wolf OT
    CNS Neurosci Ther; 2011 Dec; 17(6):714-22. PubMed ID: 21143429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid sensitivity in mood disorders.
    Spijker AT; van Rossum EF
    Neuroendocrinology; 2012; 95(3):179-86. PubMed ID: 22076031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.
    Müller MB; Uhr M; Holsboer F; Keck ME
    Neuroendocrinology; 2004 Jan; 79(1):1-12. PubMed ID: 14755129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
    Schmidt MV; Sterlemann V; Wagner K; Niederleitner B; Ganea K; Liebl C; Deussing JM; Berger S; Schütz G; Holsboer F; Müller MB
    Endocrinology; 2009 Jun; 150(6):2709-16. PubMed ID: 19213843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression.
    Swaab DF; Fliers E; Hoogendijk WJ; Veltman DJ; Zhou JN
    Prog Brain Res; 2000; 126():369-96. PubMed ID: 11105658
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
    J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.
    Bruehl H; Rueger M; Dziobek I; Sweat V; Tirsi A; Javier E; Arentoft A; Wolf OT; Convit A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2439-45. PubMed ID: 17426095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cortisol on cognition in major depressive disorder, posttraumatic stress disorder and borderline personality disorder - 2014 Curt Richter Award Winner.
    Wingenfeld K; Wolf OT
    Psychoneuroendocrinology; 2015 Jan; 51():282-95. PubMed ID: 25462901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.